|
BCRX | Biocryst Pharmaceuticals Inc |
|
|
BCRX | Biocryst Pharmaceuticals Inc |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ -0.26 |
| Leverage | 197.05% |
| Market Cap | $ 1.9B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -88.3m |
| Margin | -20.69% |
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.